Why the study?
Does the Monocyte Count/HDL Cholesterol Ratio predict Cardiovascular Disease in patients with Obstructive Sleep Apnea Syndrome?
Does the Monocyte Count/HDL Cholesterol Ratio predict Cardiovascular Disease in patients with Obstructive Sleep Apnea Syndrome?
Answers are grounded in this paper and cite their sources.
The Monocyte Count/HDL Cholesterol Ratio (MHR) may serve as a useful biomarker to predict cardiovascular disease in patients with obstructive sleep apnea syndrome.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Köseoğlu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: